Andrea Belt
Psychiatric/Mental Health · Oak Ridge, TNNPI 1104298272
Payments from drug & device makers
Across 144 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$539
- Otsuka America Pharmaceutical, Inc.$443
- AbbVie$297
- Takeda Pharmaceuticals U.S.A., Inc.$235
- Johnson & Johnson$197
- Neurocrine Biosciences, Inc.$180
- plus $615 from 11 others
What the payments were for
- Food & beverage$2,505100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 31 | $539 |
| Otsuka America Pharmaceutical, Inc. | 27 | $443 |
| AbbVie | 18 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $235 |
| Johnson & Johnson | 10 | $197 |
| Neurocrine Biosciences, Inc. | 9 | $180 |
| Alkermes, Inc. | 8 | $146 |
| Lundbeck LLC | 5 | $104 |
| Axsome Therapeutics, Inc. | 6 | $103 |
| Tris Pharma Inc | 4 | $67 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $57 |
| Idorsia Pharmaceuticals US Inc | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $31 |
| Merck | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
How this compares
$2,505 in reported general payments places this provider in the 75th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 13 | $209,318 |
| RexultiBrexpiprazole | 15 | $21,810 |
| Paliperidone ErPaliperidone | 23 | $5,893 |
| BelsomraSuvorexant | 12 | $5,361 |
| Vilazodone Hcl | 15 | $1,542 |
| Duloxetine Hcl | 48 | $988 |
| Lamotrigine | 43 | $709 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 25 | $620 |
| Aripiprazole | 22 | $538 |
| Bupropion XlBupropion Hcl | 26 | $508 |
| Trazodone Hcl | 59 | $414 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $316 |
| Sertraline Hcl | 29 | $310 |
| Buspirone Hcl | 21 | $299 |
| Eszopiclone | 15 | $290 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $539 | $209,31813 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $443 | $21,81015 claims |
| MerckBelsomra | $19 | $5,36112 claims |
| Lilly USA, LLCOlanzapine | $17 | $12411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Other psychiatric/mental health in Oak Ridge
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
- Kristian DambrinoNashville$449K
- Mary AllenMemphis$422K
- Lauren HansenNashville$263K
- Joshua ThompsonChattanooga$262K
- Kristal HurstBlaine$260K
- Kaitlynn EarlsGreeneville$228K
- Tory WoodardCookeville$191K
- Sarah VogelfangerMemphis$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.